Loading…
HeartSciences Inc. is projected to rise to $3.07 by 2027, a +12% move from its current price of $2.74. HSCS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.59 | $2.74 | $2.90 | +0.08% |
| Jul 13 | $2.54 | $2.74 | $2.97 | +0.16% |
| Jul 14 | $2.49 | $2.75 | $3.03 | +0.24% |
| Jul 15 | $2.46 | $2.75 | $3.07 | +0.31% |
| Jul 16 | $2.43 | $2.75 | $3.12 | +0.39% |
| Jul 17 | $2.40 | $2.75 | $3.16 | +0.47% |
| Jul 18 | $2.38 | $2.76 | $3.19 | +0.55% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.38 | $2.76 | $3.19 | +0.55% |
| Week 2 | $2.25 | $2.77 | $3.41 | +1.10% |
| Week 3 | $2.16 | $2.79 | $3.60 | +1.66% |
| Week 4 | $2.08 | $2.80 | $3.76 | +2.22% |
| Week 5 | $2.02 | $2.82 | $3.92 | +2.78% |
| Week 6 | $1.97 | $2.83 | $4.07 | +3.35% |
| Week 7 | $1.93 | $2.85 | $4.21 | +3.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HeartSciences Inc. is a medical technology company focused on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test.
The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
HeartSciences Inc. (HSCS) is currently priced at $2.75 per share. It has a market capitalization of $9.05M and is ranked 4863 in the market. The stock sits in a stretched but evolving long-term forecast, with a path from a near-term stable level toward higher average prices in the years ahead.
The forecast envisions a bullish trajectory through 2050, with the 2026 average price of $2.75 rising through subsequent years to an average of $14.75 by 2050, indicating meaningful upside over the long term. This implies a growing market value if the projected averages hold, though actual results may vary.
A major floor 58.2% below — a decisive break under it would weaken the trend.
The nearest floor, 39.1% below — buyers have tended to step in here.
The nearest ceiling, 9.1% above — a clean break opens room to run.
A major ceiling 38.2% above — clearing it would confirm fresh momentum.
Key HSCS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HSCS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.75 | Sell | $2.74 | Buy |
| MA 10 | $2.77 | Sell | $2.69 | Buy |
| MA 20 | $2.44 | Buy | $2.52 | Buy |
| MA 50 | $2.13 | Buy | $2.31 | Buy |
| MA 100 | $2.28 | Buy | $2.37 | Buy |
| MA 200 | $2.68 | Buy | $2.75 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.03 | Neutral |
| Stoch RSI (14) | 49.59 | Neutral |
| CCI (20) | 46.35 | Neutral |
| Williams %R (14) | -20.49 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -0.36 | Sell |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 79.51 | Neutral |
| TRIX (15) | 1.41 | Buy |
| Awesome (5,34) | 0.52 | Buy |
| Ultimate (7,14,28) | 61.93 | Neutral |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 2.73 | Buy |
| ADX (14) | 21.09 | Buy |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is bullish, with RSI14 at 70. The 50-day simple moving average is $2.02 and the 200-day simple moving average is $2.71.
Near-term support is at $1.67 and resistance is at $2.99. The 30-day price range spans from $1.93 to $3.92, reflecting upside potential within the near term while acknowledging downside risk.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.67 | $2.74 | $3.89 | 0% | Neutral | |
| $2.22 | $3.07 | $4.57 | +12% | Neutral | |
| $3.03 | $4.44 | $7.06 | +62% | Bullish | |
| $3.36 | $5.18 | $8.63 | +89% | Bullish | |
| $3.23 | $5.22 | $9.06 | +91% | Bullish | |
| $2.82 | $4.76 | $8.56 | +74% | Bullish | |
| $2.75 | $4.86 | $9.00 | +77% | Bullish | |
| $2.68 | $4.92 | $9.37 | +80% | Bullish | |
| $2.45 | $4.68 | $9.13 | +71% | Bullish | |
| $3.37 | $6.69 | $13.37 | +144% | Bullish | |
| $3.09 | $6.87 | $15.09 | +151% | Bullish | |
| $7.96 | $17.69 | $40.68 | +546% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.67 | $2.74 | $3.42 | +0.00% |
| August 2026 | $2.50 | $3.02 | $3.82 | +10.38% |
| September 2026 | $2.39 | $2.94 | $3.79 | -2.69% |
| October 2026 | $2.19 | $2.73 | $3.58 | -7.32% |
| November 2026 | $2.24 | $2.82 | $3.75 | +3.26% |
| December 2026 | $2.28 | $2.89 | $3.89 | +2.60% |
Click any year to see its month-by-month HSCS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
HeartSciences Inc.'s 2026 outlook centres on $2.74, within a $1.67 to $3.89 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, HSCS could reach as high as $4.57, with a base case around $3.07 and support toward $2.22 — roughly +12% from $2.74. A consolidation phase looks the most probable path here.
Expect HSCS to range from $3.03 to $7.06 through 2028. The $4.44 average target implies a +62% move from current prices. That is up +45% on the projected 2027 average. Momentum favours further upside here.
The HSCS price prediction for 2029 points to an average of $5.18 (low $3.36, high $8.63) — a potential gain of +89% on today's $2.74. Buyers look set to stay in control over this stretch.
In 2030, HSCS is projected to trade between $3.23 and $9.06, averaging $5.22 — a potential gain of +91% from today's $2.74. That is up +1% on the projected 2029 average. Momentum favours further upside here.
HeartSciences Inc.'s 2031 outlook centres on $4.76, within a $2.82 to $8.56 range. That is -9% versus the projected 2030 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, HSCS could reach as high as $9.00, with a base case around $4.86 and support toward $2.75 — roughly +77% from $2.74. Momentum favours further upside here.
Expect HSCS to range from $2.68 to $9.37 through 2033. The $4.92 average target implies a +80% move from current prices. That is up +1% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The HSCS price prediction for 2034 points to an average of $4.68 (low $2.45, high $9.13) — a potential gain of +71% on today's $2.74. Momentum favours further upside here.
In 2035, HSCS is projected to trade between $3.37 and $13.37, averaging $6.69 — a potential gain of +144% from today's $2.74. That is up +43% on the projected 2034 average. Buyers look set to stay in control over this stretch.
HeartSciences Inc.'s 2040 outlook centres on $6.87, within a $3.09 to $15.09 range. That is up +3% on the projected 2035 average. That marks a +151% change versus current levels. Momentum favours further upside here.
By 2050, HSCS could reach as high as $40.68, with a base case around $17.69 and support toward $7.96 — roughly +546% from $2.74. Buyers look set to stay in control over this stretch.
Investing $1,000 in HSCS today (≈ 364.963504 HSCS) could be worth
$6,455.66
+$5,455.66 (+546%) by 2050 · US Dollar
Based on the average projected HSCS price of $17.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HSCSwould be worth at today's price.
$1,000 invested in HSCS on Jul 10, 2025 (≈ 174.520069 HSCS) would be worth
$478.18
-$521.82 (-52.2%) today · 0.48× · US Dollar
Based on a HSCS entry price of $5.73 vs. today's $2.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.79 | $982.08 | -1.8% |
| 1 month ago | $1.88 | $1,457.45 | +45.7% |
| 3 months ago | $2.08 | $1,317.31 | +31.7% |
| 6 months ago | $3.17 | $864.35 | -13.6% |
| 1 year ago | $5.73 | $478.18 | -52.2% |
| All time (4.1y) ago | $242 | $11.32 | -98.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HSCS forecast.
Our base-case forecast reaches $5.50 around 2035.
Implied market cap at $5.50: $18.1M
The multi-year forecast shows a bullish trajectory beyond 2026. For 2026 the average price is $2.75 with a min of $1.67, a max of $3.79, and a ROI of 0%; 2027 carries an average of $2.88 with min $2.08, max $4.30, and ROI of 4.7%. The 2028 forecast increases to an average of $4.26 (min $2.90, max $6.78) with a 54.9% ROI, and 2029 to an average of $4.75 (min $3.07, max $7.93) with a 72.6% ROI, followed by 2030 at an average of $4.77 (min $2.95, max $8.29) and a 73.6% ROI.
From 2031 to 2034 the averages remain bullish, with 2031 at $4.58 (ROI 66.6%), 2032 at $4.43 (ROI 61.2%), 2033 at $4.45 (ROI 61.7%), and 2034 at $4.29 (ROI 56.1%). The 2035 forecast shows a notable step up to an average of $5.75 with a max of $11.49 and ROI of 109% in a bullish phase. By 2040 the average is projected at $6.30 with a max of $13.83 and ROI of 129%.
By 2050, the average is forecast at $14.75 with a max of $33.93 and ROI of 436.4%, continuing the bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $4.77 with a min of $2.95 and a max of $8.29, and a ROI of 73.6%; sentiment is BULLISH. These are estimates and not guarantees.
Forecasts indicate a bullish sentiment from 2028 onward, with the average price rising to $14.75 by 2050 and ROIs up to 436.4%; the current price is $2.75. These are estimates and not guarantees.
Yes, the forecast shows potential to exceed $10, with 2035 max $11.49 and 2040 max $13.83; 2050 max $33.93. These are estimates and not guarantees.
Current price is $2.75 and market cap is $9.05M. These are estimates and not guarantees.
RSI14 is 70; the 50-day SMA is $2.02 and the 200-day SMA is $2.71. The 30-day range is $1.93–$3.92 with support at $1.67 and resistance at $2.99. These are estimates and not guarantees.
HeartSciences Inc. Community Discussion
0Share your HeartSciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.